Curocell is a cell therapy company that discovers and develops CAR-T therapies for cancer. The company's current efforts focus on unleashing the body’s immune system through broad-spectrum CAR-T technologies to treat blood cancers, as well as solid cancers. The company's programmed T cell product candidates are differentiated by incorporation of T cell modifying technology designed to effectively overcoming the immune suppression, and thereby offers greater efficacy compared to the current CAR-T cell technology.
| Website | https://www.curocellbtx.com/ |
| Employees | 26 (14 on RocketReach) |
| Founded | 2016 |
| Industry | Biotechnology Research |
| Keywords | Car T Cell Therapy, Cancer Treatment, Immunotherapy, Cell Therapy Research, Blood Cancer Treatment, Cancer Immunotherapy, Cellular Therapies, Hematologic Malignancies, Innovative Cancer Treatments, Oncology Therapeutics, Advanced Therapies, Biopharmaceutical, Drug Development, Precision Medicine, Targeted Therapies, Clinical Trials, Regenerative Medicine, Biotechnology |
| Competitors | Ipsen, Galderma, Revance, Actavis plc (now Allergan), Sientra, Inc., Medytox, Hugel Inc. +37 more (view full list) |
Looking for a particular Curocell employee's phone or email?
Curocell Questions
Seungwon Lee is the Senior Director Business Development of Curocell.
14 people are employed at Curocell.
Top Curocell Employees
-
2
-
Joonmo Koo
QA Manager at Curocell
South Korea1 -
Gena Meyers
BD | MSAT Team Lead at Curocell
Los Angeles, CA, US2 -
Mi-Seong Jeon
과장 at Curocell
Seoul, South Korea -
영삼 박
이사 at Curocell
None
Related Companies
